Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Topical phenylephrine increases anal sphincter resting pressure.
Carapeti EA, Kamm MA, Evans BK, Phillips RK. Carapeti EA, et al. Br J Surg. 1999 Feb;86(2):267-70. doi: 10.1046/j.1365-2168.1999.01021.x. Br J Surg. 1999. PMID: 10100801
Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel.
Green JT, McKirdy HC, Rhodes J, Thomas GA, Evans BK. Green JT, et al. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1299-304. doi: 10.1097/00042737-199911000-00020. Eur J Gastroenterol Hepatol. 1999. PMID: 10563544 Clinical Trial.
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
Green JT, Evans BK, Rhodes J, Thomas GA, Ranshaw C, Feyerabend C, Russell MA. Green JT, et al. Br J Clin Pharmacol. 1999 Oct;48(4):485-93. doi: 10.1046/j.1365-2125.1999.00057.x. Br J Clin Pharmacol. 1999. PMID: 10583017 Free PMC article. Clinical Trial.
Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.
Ingram JR, Routledge P, Rhodes J, Marshall RW, Buss DC, Evans BK, Feyerabend C, Thomas GA. Ingram JR, et al. Among authors: evans bk. Aliment Pharmacol Ther. 2004 Oct 15;20(8):859-65. doi: 10.1111/j.1365-2036.2004.02199.x. Aliment Pharmacol Ther. 2004. PMID: 15479357 Free article.
Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK, Rhodes JR, Evans B, Holt PJ. Patel GK, et al. J Dermatolog Treat. 2004 Apr;15(2):122-5. doi: 10.1080/09546630310019364. J Dermatolog Treat. 2004. PMID: 15204166
Nicotine enemas for active ulcerative colitis--a pilot study.
Green JT, Thomas GA, Rhodes J, Williams GT, Evans BK, Russell MA, Feyerabend C, Rhodes P, Sandborn WJ. Green JT, et al. Aliment Pharmacol Ther. 1997 Oct;11(5):859-63. doi: 10.1046/j.1365-2036.1997.00220.x. Aliment Pharmacol Ther. 1997. PMID: 9354193 Clinical Trial.
Effect of an enteric-release formulation of naloxone on intestinal transit in volunteers taking codeine.
Hawkes ND, Richardson C, Evans BK, Rhodes J, Lewis SJ, Thomas GA. Hawkes ND, et al. Aliment Pharmacol Ther. 2001 May;15(5):625-30. doi: 10.1046/j.1365-2036.2001.00970.x. Aliment Pharmacol Ther. 2001. PMID: 11328255 Clinical Trial.
Enteric-release glyceryl trinitrate in active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Hawkes ND, Richardson C, Ch'Ng CL, Green JT, Evans BK, Williams J, Rhodes P, Rhodes J, Swift GL, Thomas GA, Hawthorne AB, Kingham JG, Mayberry JF. Hawkes ND, et al. Aliment Pharmacol Ther. 2001 Dec;15(12):1867-73. doi: 10.1046/j.1365-2036.2001.01120.x. Aliment Pharmacol Ther. 2001. PMID: 11736716 Clinical Trial.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
87 results
Jump to page
Feedback